Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

43.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 49.42p
  • 52 Week Low: 26.50p
  • Currency: UK Pounds
  • Shares Issued: 667.69m
  • Volume: 96,789
  • Market Cap: 287.10m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-20 Q3 24.54 (8.54) (1.19)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-15 44.20 (11.36) (1.13)p n/a n/a n/a n/a 0.0%
30-Sep-16 109.38 (22.38) (1.26)p n/a n/a n/a n/a 0.0%
30-Sep-17 140.17 (8.10) (1.43)p n/a n/a n/a n/a 0.0%
30-Sep-18 131.64 (8.43) (0.03)p n/a n/a n/a n/a 0.0%
30-Sep-19 127.34 (73.30) (13.26)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-20 115.21 (22.30) (3.89)p n/a n/a n/a n/a 0.0%
30-Sep-21 129.46 (4.07) (1.23)p n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 43.00p
Change Today -0.50p
% Change -1.15 %
52 Week High 49.42p
52 Week Low 26.50p
Volume 96,789
Shares Issued 667.69m
Market Cap 287.10m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.44% below the market average6.44% below the market average6.44% below the market average6.44% below the market average6.44% below the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Price Trend
24.88% above the market average24.88% above the market average24.88% above the market average24.88% above the market average24.88% above the market average
44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average44.83% below the sector average
Income Not Available
Growth
31.45% below the market average31.45% below the market average31.45% below the market average31.45% below the market average31.45% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 30-Sep-2020

Time Volume / Share Price
14:36 20,000 @ 43.60p
14:33 10,000 @ 43.55p
14:13 10,000 @ 43.50p
13:52 2,298 @ 43.50p
10:00 7,568 @ 43.60p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen

Top of Page